Magnasense AB (OSTO:MAGNA) ROCE % : -135.47% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Magnasense AB's annualized ROCE % for the quarter that ended in Sep. 2024 was -135.47%.

Magnasense AB ROCE % Historical Data

The historical data trend for Magnasense AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB ROCE % Chart

Magnasense AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-51.14

-41.58

-167.26

-110.89

Magnasense AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-105.86	-39.77	-32.59	-11.48	-135.47

Magnasense AB ROCE % Calculation

Magnasense AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-51.188	/	( ( (66.87 - 17.277)	+	(53.102 - 10.373) )	/ 2 )
	=	-51.188	/	( (49.593	+	42.729)	/ 2 )
	=	-51.188	/	46.161
	=	-110.89 %

Magnasense AB's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-47.86	/	( ( (47.873 - 9.427)	+	(49.854 - 17.642) )	/ 2 )
	=	-47.86	/	( ( 38.446	+	32.212 )	/ 2 )
	=	-47.86	/	35.329
	=	-135.47 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Magnasense AB (OSTO:MAGNA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Magnasense AB ROCE % Related Terms

Thank you for viewing the detailed overview of Magnasense AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Magnasense AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (OSTO:MAGNA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines